{"id":754170,"date":"2023-05-03T07:34:52","date_gmt":"2023-05-03T11:34:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/"},"modified":"2023-05-03T07:34:52","modified_gmt":"2023-05-03T11:34:52","slug":"gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/","title":{"rendered":"Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023"},"content":{"rendered":"<h2>\n&#8212; Conference call to begin at 4:30pm ET on May 11 &#8212;<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">EMERYVILLE, Calif., May  03, 2023  (GLOBE NEWSWIRE) &#8212; Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world\u2019s most potent vaccines, today announced it will report its first quarter 2023 financial results and provide a corporate update following market close on Thursday, May 11, 2023. The announcement will be followed by a conference call and audio webcast, which will begin at\u00a04:30pm ET.<\/p>\n<p>\n        <strong><br \/>\n          <u>Live Conference Call &amp; Webcast<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>Toll Free: 1-888-999-6281<br \/>International: 1-848-280-6550<br \/>Conference ID: 1754341<br \/>Webcast: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1lHI-3tzZH4v9Y9oF10fEP2zeFUfn9ZCtycvz9zNo_OyJEL7OY3N9-pOAt-h7e-7BqtEl1igyq5DDeWQTEjQeChKKrswNgKjrwMygTCrahCPfIIHtcE-h2Q_WJ8tuHKs3kg8pUSY7uyI-d2g7yzLhrRnbWbYwsR_xEZsNAnw_cxWlqLDDQk2v0I6dTP6-xLhMhEM-R5nviEdNY2xm0OhiKwfDOJh7KMnbPqz_oy7C7k=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1612896&amp;tp_key=c6c637ac24<\/a><\/p>\n<p>While not required, it is recommended you join five minutes prior to the event\u2019s start. An archived replay will be accessible at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1lHI-3tzZH4v9Y9oF10fEG6H7BeRrUDHFCyJJcPHwpC9jSrC87q-D6j2XBbGDcuFFNDlL3fcEI32bE_mwgKEYn0kk6DHzsAUYYOyzernUWjK46Un4f8t6XlwTO1XJ-z857rmVsHF05KLK3ByQ_GxvA==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.gritstonebio.com\/investors\/events<\/a> for 30 days following the event.<\/p>\n<p>\n        <strong>About Gritstone bio<\/strong><br \/>\n        <br \/>Gritstone is working to create the world\u2019s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets and have programs in viral diseases and solid tumors. Independently and with our partners, we are advancing a portfolio of product candidates with the aim of improving patient outcomes and eliminating disease. <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aZUiBlRS3M9wqIJYAwJHBWscKvZUXhPqKGnDIF5GCgXjc2rRvuCTolvA6ZNfvcbGfXy_aKF6BBdZdpf853hK2JLDHGbKyy-5z_9LZaaXMoc=\" rel=\"nofollow noopener\" target=\"_blank\">www.gritstonebio.com<\/a><\/p>\n<p>\n        <strong>Gritstone Forward-Looking Statements<\/strong><br \/>\n        <br \/>This press release contains forward-looking statements, including, but not limited to, statements related to the potential of Gritstone\u2019s therapeutic programs; the advancements in Gritstone\u2019s ongoing clinical trials; the timing of data announcements related to ongoing clinical trials and the initiation of future clinical trials. Such forward-looking statements involve substantial risks and uncertainties that could cause Gritstone\u2019s research and clinical development programs, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties inherent in the drug development process, including Gritstone\u2019s programs\u2019 clinical stage of development, the process of designing and conducting preclinical and clinical trials, the regulatory approval processes, the timing of regulatory filings, the challenges associated with manufacturing drug products, Gritstone\u2019s ability to successfully establish, protect and defend its intellectual property and other matters that could affect the sufficiency of existing cash to fund operations. Gritstone undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of the company in general, see Gritstone\u2019s most recent Annual Report on Form 10-K filed on March 9, 2023 and any current and periodic reports filed with the Securities and Exchange Commission.<\/p>\n<p>\n        <strong><br \/>\n          <u>Gritstone Contacts<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>Investors:<br \/>George E. MacDougall<br \/>Director, Investor Relations &amp; Corporate Communications<br \/>Gritstone bio, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gF-qGymkITnwcefJmaSWDPj838FHlk9SFLRkRsJ37kUAj2e_6uhoJn4MxoBR7UpIfDZnbQTkZeB1rW3oon8jyQ==\" rel=\"nofollow noopener\" target=\"_blank\">ir@gritstone.com<\/a><\/p>\n<p>\n        <u>Media<\/u>:<br \/>Dan Budwick<br \/>1AB<br \/>(973) 271-6085<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yfH0ALIU1UByF0Sm7Sk1bv9X2dub-9INVAIDQRui-U3trnQOwlvolkOtvUMkKQJLWqJxiLJADc-RnhanxNyYlQ==\" rel=\"nofollow noopener\" target=\"_blank\">dan@1abmedia.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QKGIwtVc4gC8fSC1W00_A4rYLrlmqnueEVG18e-sKEuc1OdhL38myEIR_ZaVZZF2\" rel=\"nofollow noopener\" target=\"_blank\"><br \/><\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDYzNSM1NTcwMzY1IzIxMjM1MTQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OTgxYWU0YTItMGQ5My00NDMyLTgzZTAtNDc1NzBmMDk4NWI4LTExMzUwODU=\/tiny\/Gritstone-bio-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>&#8212; Conference call to begin at 4:30pm ET on May 11 &#8212; EMERYVILLE, Calif., May 03, 2023 (GLOBE NEWSWIRE) &#8212; Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world\u2019s most potent vaccines, today announced it will report its first quarter 2023 financial results and provide a corporate update following market close on Thursday, May 11, 2023. The announcement will be followed by a conference call and audio webcast, which will begin at\u00a04:30pm ET. Live Conference Call &amp; Webcast Toll Free: 1-888-999-6281International: 1-848-280-6550Conference ID: 1754341Webcast: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1612896&amp;tp_key=c6c637ac24 While not required, it is recommended you join five minutes prior to the event\u2019s start. An archived replay will be accessible at https:\/\/ir.gritstonebio.com\/investors\/events for 30 days following the event. About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-754170","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"&#8212; Conference call to begin at 4:30pm ET on May 11 &#8212; EMERYVILLE, Calif., May 03, 2023 (GLOBE NEWSWIRE) &#8212; Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world\u2019s most potent vaccines, today announced it will report its first quarter 2023 financial results and provide a corporate update following market close on Thursday, May 11, 2023. The announcement will be followed by a conference call and audio webcast, which will begin at\u00a04:30pm ET. Live Conference Call &amp; Webcast Toll Free: 1-888-999-6281International: 1-848-280-6550Conference ID: 1754341Webcast: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1612896&amp;tp_key=c6c637ac24 While not required, it is recommended you join five minutes prior to the event\u2019s start. An archived replay will be accessible at https:\/\/ir.gritstonebio.com\/investors\/events for 30 days following the event. About &hellip; Continue reading &quot;Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-03T11:34:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDYzNSM1NTcwMzY1IzIxMjM1MTQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023\",\"datePublished\":\"2023-05-03T11:34:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\\\/\"},\"wordCount\":477,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDYzNSM1NTcwMzY1IzIxMjM1MTQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\\\/\",\"name\":\"Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDYzNSM1NTcwMzY1IzIxMjM1MTQ=\",\"datePublished\":\"2023-05-03T11:34:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDYzNSM1NTcwMzY1IzIxMjM1MTQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMDYzNSM1NTcwMzY1IzIxMjM1MTQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/","og_locale":"en_US","og_type":"article","og_title":"Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023 - Market Newsdesk","og_description":"&#8212; Conference call to begin at 4:30pm ET on May 11 &#8212; EMERYVILLE, Calif., May 03, 2023 (GLOBE NEWSWIRE) &#8212; Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world\u2019s most potent vaccines, today announced it will report its first quarter 2023 financial results and provide a corporate update following market close on Thursday, May 11, 2023. The announcement will be followed by a conference call and audio webcast, which will begin at\u00a04:30pm ET. Live Conference Call &amp; Webcast Toll Free: 1-888-999-6281International: 1-848-280-6550Conference ID: 1754341Webcast: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1612896&amp;tp_key=c6c637ac24 While not required, it is recommended you join five minutes prior to the event\u2019s start. An archived replay will be accessible at https:\/\/ir.gritstonebio.com\/investors\/events for 30 days following the event. About &hellip; Continue reading \"Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-03T11:34:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDYzNSM1NTcwMzY1IzIxMjM1MTQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023","datePublished":"2023-05-03T11:34:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/"},"wordCount":477,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDYzNSM1NTcwMzY1IzIxMjM1MTQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/","name":"Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDYzNSM1NTcwMzY1IzIxMjM1MTQ=","datePublished":"2023-05-03T11:34:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDYzNSM1NTcwMzY1IzIxMjM1MTQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMDYzNSM1NTcwMzY1IzIxMjM1MTQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gritstone-bio-to-report-first-quarter-2023-financial-results-and-provide-corporate-update-on-may-11-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=754170"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754170\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=754170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=754170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=754170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}